| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |